CL
Chloé Lozac’h
Associate, Chief of Staff at BroadPeak Capital
· United States
Check size
$200K - $1M
Lead stage
pre-seed
Deals tracked
22
Sectors
Healthcare, Deep Tech
Healthcare
Deep Tech
Frontier Technologies
deep tech
healthcare
robotics
pre-seed
seed
Series A
growth
global
United States
Europe
Africa
Latin America
About Chloé
Chloé Lozac'h is a Venture Partner at VU Venture Partners and Deal Partner at Ganas, a pre-seed fund backing mission-driven founders in the U.S. and Latin America. She invests across early-stage startups in deep tech, healthtech, robotics, space tech, longevity, and sports tech, with portfolio exposure to frontier innovations including artificial wombs, nanomedicine, and human performance technologies. Beyond venture capital, she manages a multi-million-euro real estate portfolio in Europe and advises startups on business model scalability and investor readiness
Investment thesis
Operationally driven investor backing early-stage founders across deep tech, health, and frontier technologies.
VU Venture Partners is a global multi-stage venture capital fund that invests across consumer, enterprise, fintech, frontier, healthcare, and proptech sectors. The firm deploys $200K–$1M initial investments through pre-seed to growth stages, targeting a minimum 10x return inclusive of dilution. The firm builds diversified portfolios of ~60 companies over 3–4 years while reserving 50–66% for follow-on capital concentrated in ~20 portfolio companies. Geographically, VU allocates roughly 66% to the U.S. and 33% to rest of world (Canada, LatAm, Europe, Asia-Pacific, Middle East, and Africa). Chloé Lozac'h, as a Venture Partner on the Healthcare Team, focuses on operationally driven investment in early-stage founders building bold solutions across deep tech, health, and frontier technologies
Investment philosophy
Chloé Lozac'h describes herself as a venture capital investor and entrepreneur focused on backing bold founders building for humanity, health, and technology. Her background combines investing, startup support, and real-estate management, with an emphasis on long-term value creation, cross-border perspective, and founder readiness.
Investment focus
Early-stage (pre-seed to seed) frontier technologies and mission-driven founders, with deep sector expertise in deep tech, biotech, healthtech, and robotics. Geography-agnostic approach spanning U.S., Latin America, Africa, Europe, and North America
Areas of expertise
Notable portfolio
3DBiocorp
BrainHI
Contraline
Insite Health
Jumpstart Fertility
MobileODT
Nutromics
Redcliffe Labs
Adrenomed
Cellbricks
Enclear Therapies
Inventia Life
Our Health Mate
Torramics
AOADX
Notable deals
Artificial wombs – frontier biotech (stage/date unknown)
Nanomedicine – deep tech therapeutics (stage/date unknown)
Nano-pump drug delivery – biotech platform (stage/date unknown)
3D-printed organoids for AI-driven drug discovery – biotech (stage/date unknown)
Vertical shrimp farming – agritech (stage/date unknown)
Frequently asked
Does Chloé Lozac’h invest at pre-seed stage?
Yes. They invest at pre-seed, seed, Series A stage.
Their geographic focus includes global, United States, Europe.
What is their typical check size?
Chloé Lozac’h's typical check size is $200K - $1M.
They currently invest through BroadPeak Capital.
What sectors does Chloé Lozac’h focus on?
Chloé Lozac’h primarily invests in Healthcare, Deep Tech, Frontier Technologies, deep tech.
Similar Healthcare investors
PM
Pankaj Mitra
AI/ML · $1M - $30M
LS
LLC Sydecar
Healthcare · Undisclosed
Amitabh Shrivastava
Finance · ₹15 crore average initial investment
TODD WATTS
Healthcare fintech · Undisclosed
Sign up for free to unlock similar investors
Are you a fit for Chloé Lozac’h?
See your match score free · under a minute